Komori
Semiannual Report4558CHUKYO IYAKUHIN CO.,LTD.Pharmaceuticals

Semiannual Report — FY2026 H1

What CHUKYO IYAKUHIN CO.,LTD. reported for the period from 2026-04-01 to 2027-03-31.

How much it says
50Typical
What moved here
10named for the first time
Its own wording
20terms
Which filing this is
38/ 38newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the current interim accounting period, net sales increased, while operating profit, ordinary profit and interim net income all fell below the levels recorded in the same period of the previous year. In addition, the Company resolved in October 2026 to acquire a business involving the transfer of customers in certain regions from 前花薬品株式会社 and entered into an agreement to that effect, with the effective date set for 1 January 2027.

Komori's summary of this document, not the document's own words.
50Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
Magnitude of change
31
Thin
Strategic shift
67
Detailed
Capital movement
100
Very detailed
Disclosure gaps
0
Almost nothing
Risk changes
37
Thin
Finance and capital policy
62
Detailed
Specificity of disclosure
7
Almost nothing
Product portfolio
55
Typical
Technology position
73
Detailed
Confidence in strategic bets
R&D spendNot disclosedThis document does not carry the figure.
Cash left over11百万円Cash from the business, less what went into equipment.
Spent on equipment32百万円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.
CHUKYO IYAKUHIN CO.,LTD. — FY2026 H1 | Komori